Literature DB >> 3180470

Enzyme-linked immunosorbent assay (ELISA) for human tumor necrosis factor (hTNF).

Y Abe1, M Miyake, T Sagawa, S Kimura.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3180470     DOI: 10.1016/0009-8981(88)90210-0

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


× No keyword cloud information.
  7 in total

Review 1.  Immunomodulatory action of intravenous immunoglobulin.

Authors:  W A C Sewell; S Jolles
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

Review 2.  Clinical uses of intravenous immunoglobulin.

Authors:  S Jolles; W A C Sewell; S A Misbah
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

3.  The endogenous induction of tumor necrosis factor serum (TNS) for the adjuvant postoperative immunotherapy of cancer--changes in immunological markers of the blood.

Authors:  Y Abe; M Miyake; T Miyazaki; A Horiuchi; S Kimura
Journal:  Jpn J Surg       Date:  1990-01

4.  In vivo modulation of cytokine synthesis by intravenous immunoglobulin.

Authors:  W A Sewell; M E North; R Cambronero; A D Webster; J Farrant
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

5.  Changes in the productivity of cytokines and active-oxygen in peripheral blood cells following surgery.

Authors:  Y Abe; M Miyake; A Horiuchi; K Kumori; S Kimura
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

6.  Natural human IgG inhibits the production of tumor necrosis factor-alpha and interleukin-1 alpha through the Fc portion.

Authors:  A Horiuchi; Y Abe; M Miyake; Y Osuka; S Kimura
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

7.  The elevation of plasma soluble tumor necrosis factor receptor levels by TNF induction therapy for patients with malignancy.

Authors:  Y Abe; K Kimura; A Horiuchi; Y Watanabe; S Kimura
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.